Open AccessAssessment of the application for renewal of authorisation of 6‐phytase produced by Trichoderma reesei CBS 122001 as a feed additive for pigs and poultry, from Roal Oy
Author(s) -
Bampidis Vasileios,
Azimonti Giovanna,
Bastos Maria de Lourdes,
Christensen Henrik,
Dusemund Birgit,
Fašmon Durjava Mojca,
Kouba Maryline,
LópezAlonso Marta,
López Puente Secundino,
Marcon Francesca,
Pechová Alena,
Petkova Mariana,
Ramos Fernando,
Sanz Yolanda,
Villa Roberto Edoardo,
Woutersen Ruud,
Cocconcelli Pier Sandro,
Glandorf Boet,
Herman Lieve,
Prieto Miguel Maradona,
Saarela Maria,
Brozzi Rosella,
Galobart Jaume,
Innocenti Matteo,
LópezGálvez Gloria,
Pettenati Elisa,
Revez Joana,
Sofianidis Konstantinos,
Vettori Maria Vittoria,
Gregoretti Lucilla,
Mayo Baltasar
Publication year - 2020
Publication title -
efsa journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.076
H-Index - 97
ISSN - 1831-4732
DOI - 10.2903/j.efsa.2020.6336
Subject(s) - authorization , european commission , context (archaeology) , business , phytase , feed additive , food science , animal feed , microbiology and biotechnology , biology , european union , computer science , computer security , economic policy , enzyme , paleontology , biochemistry , broiler
Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed ( FEEDAP ) was asked to deliver a scientific opinion on the assessment of the application for renewal of authorisation of 6‐phytase produced by Trichoderma reesei CBS 122001 (brand name: Finase ® EC ). The applicant has provided evidence that the additive currently in the market complies with the existing conditions of authorisation. The Panel concludes that the additive remains safe for poultry for fattening, breeding and laying, and all pigs, the consumer and the environment under the authorised conditions of use. Regarding user safety, the Panel reiterates that the additive is not a skin or eye irritant or sensitiser but should be considered a potential respiratory sensitiser. There is no need for assessing the efficacy of the additive in the context of the renewal of the authorisation. These conclusions also apply to the new proposed liquid formulation Finase ® EC 5 L.